Scarica l'app Stockscreener
0.06
4.15%
-0.0026
Pre-mercato:
.06
Precedente Chiudi:
$0.0626
Aprire:
$0.0601
Volume 24 ore:
14.17M
Relative Volume:
0.65
Capitalizzazione di mercato:
$6.69M
Reddito:
-
Utile/perdita netta:
$-37.28M
Rapporto P/E:
-0.0769
EPS:
-0.78
Flusso di cassa netto:
$-32.24M
1 W Prestazione:
-30.23%
1M Prestazione:
-29.66%
6M Prestazione:
-94.59%
1 anno Prestazione:
-96.10%
Intervallo 1D:
$0.0551
$0.0625
Intervallo di 1 settimana:
$0.0551
$0.0857
Portata 52W:
$0.0551
$2.57
Eyenovia Inc Stock (EYEN) Company Profile
Nome
Eyenovia Inc
Settore
Industria
Telefono
813-766-9539
Indirizzo
295 MADISON AVENUE,, NEW YORK, NY
Confronta EYEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EYEN
Eyenovia Inc
|
0.06 | 6.69M | 0 | -37.28M | -32.24M | -0.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2021-03-01 | Iniziato | Northland Capital | Outperform |
| 2020-02-03 | Downgrade | Oppenheimer | Outperform → Perform |
Eyenovia Inc Borsa (EYEN) Ultime notizie
Financial Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) & Eyenovia (NASDAQ:EYEN) - Defense World
Eyenovia secures $1 million from warrant repricing and exercise - MSN
Eyenovia secures $1 million from warrant repricing and exercise By Investing.com - Investing.com Canada
SEC Form 424B3 filed by Eyenovia Inc. - Quantisnow
Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote 'FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - The Manila Times
Eyenovia Announces Leading Proxy Advisory Firms, ISS and - GlobeNewswire
Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - GlobeNewswire Inc.
Ladenburg Thalmann Downgrades Eyenovia (EYEN) - MSN
Geode Capital Management LLC Increases Stock Position in Eyenovia, Inc. (NASDAQ:EYEN) - Defense World
Deal Dispatch: TD Bank To Sell Charles Schwab Stake? Eyenovia, Smart Share Hit Auction Block - Benzinga
Mydriasis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight - The Globe and Mail
Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia Inc - The Globe and Mail
Eyenovia Eyes Cost-Cutting Measures Amid Disappointing Study Results - MPO-mag
Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA - openPR
Eyenovia explores strategic alternatives, advances Optejet device By Investing.com - Investing.com Nigeria
Eyenovia Hires Financial Adviser Amid Business Review - MarketWatch
Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - GlobeNewswire
Eyenovia explores strategic alternatives, advances Optejet device - Investing.com
Eyenovia Explores Strategic Alternatives, Accelerates Optejet Device Development Plans - StockTitan
Eyenovia (NASDAQ:EYEN) Enters into Amended and Restated Sales Agreement with Chardan Capital Markets, LLC - Defense World
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
SEC Form 424B5 filed by Eyenovia Inc. - Quantisnow
Eyenovia faces Nasdaq delisting over low stock price By Investing.com - Investing.com Nigeria
Eyenovia faces Nasdaq delisting over low stock price - Investing.com
Eyenovia (NASDAQ:EYEN) Announces Completion of Registered Direct Offering - Defense World
Eyenovia’s $1.9M Offering to Boost Optejet Development - TipRanks
Form 424B5 EYENOVIA, INC. - StreetInsider.com
Eyenovia announces pricing of $1.9M registered direct offering - MSN
Eyenovia secures $1.9 million in direct offering By Investing.com - Investing.com Canada
Eyenovia secures $1.9 million in direct offering - Investing.com
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - GlobeNewswire
Eyenovia Announces $1.9M Direct Offering to Fund Optejet Development, Strategic Growth - StockTitan
These Numbers Show Just How Powerful Eyenovia Inc (NASDAQ: EYEN) Stock Is - Stocks Register
Eyenovia, Inc. (NASDAQ:EYEN) Short Interest Update - Defense World
Eyenovia’s Direct Offering to Support Strategic Initiatives - TipRanks
Eyenovia secures $1.3 million in direct offering By Investing.com - Investing.com South Africa
Eyenovia defers loan payments, issues equity to lenders - Investing.com
Eyenovia defers loan payments, issues equity to lenders By Investing.com - Investing.com Canada
Eyenovia Slumps On Pricing Of Registered Direct Offering - Nasdaq
Eyenovia Restructures Finances and Leadership Team - TipRanks
Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering - The Manila Times
Eyenovia secures $1.3 million in direct offering - Investing.com
Eyenovia Raises $1.3M in Direct Offering at $0.1076 Per Share with Warrants | EYEN Stock News - StockTitan
Eyenovia Inc Azioni (EYEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):